Medtide Inc. (MEDTIDE) has filed its monthly return for the period ended 30 September 2026, confirming that both authorised and issued share capital remained unchanged during the month.

Total authorised and issued H shares stood firm at 141.80 million, each with a par value of RMB 1, leaving the company’s registered share capital unchanged at RMB 141.80 million. No treasury shares were held, issued, repurchased or cancelled over the period.

The company also reported: • No movements in share options, warrants, convertible securities or other share-issuance arrangements. • Full compliance with Hong Kong Main Board Rule 13.32B, maintaining a public float above the 25% minimum threshold based on publicly available information.

The filing, submitted on 6 October 2026 by Company Secretary Chan Ching, underscores a month of capital stability without dilution or restructuring activities for MEDTIDE shareholders.